CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
皮肤病学临床转化研究
基本信息
- 批准号:6532924
- 负责人:
- 金额:$ 12.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-08-21 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:acne aging antioxidants burn therapy clinical research clinical trials collagen fibrosis free radical oxygen health science research human subject human therapy evaluation immunotherapy interleukin 10 keloid skin disorder medical education phototherapy psoriasis radiation dosage role model scars scleroderma skin disorder training ultraviolet therapy
项目摘要
This application is in response to the Mid-career Investigator Award in Patient-Oriented Research (PA-98-053) which was created to support young, active and successful clinical investigators to overcome some of the major barriers to patient-oriented research: time, resource and mentoring. Dr. Sewon Kang represents such a clinical researcher with years of specialty training and commitment to mentoring the next generation of clinical investigators. The objectives of this program are to further establish the candidate's independent patient-oriented clinical research program, especially in clinical translational research, and to provide him the time and resources necessary to mentor trainees pursuing clinical investigations in skin. The areas of activity of this project are Dr. Kang's research plan focused on therapeutic use of ultraviolet (UV)-A1 radiation in fibrosing skin diseases, effects of antioxidants in UV-signaling relevant to photoaging in human skin in vivo, and interleukin-10 in psoriasis, along with his plans for mentoring beginning clinical investigators. The three projects allow, in addition to the more traditional avenue of training in sound study design, execution, and analysis, opportunities for a novel avenue for training of clinical investigators to use tools required for reproducible observation and reliable documentation of molecular phenomenon relevant to human disease. The candidate has an established record of providing mentorship to pre- and post-doctoral trainees. Dr. Kang's research program will provide the context for him to continue to train beginning clinical investigators. His research and mentoring programs will be supported by the outstanding clinical research and training programs of the University of Michigan. These include the recently awarded institutional curriculum to teach the essentials of clinical research to young trainees and junior faculty (K-30), a well- funded General Clinical Research Center, the Center for Clinical Investigation and Therapeutics, educational program in Clinical Research Design and Statistical Analysis, and the School of Public Health. In summary, the candidate's expertise and accomplishments in patient-oriented research, his ability and commitment to mentor beginning clinical investigators, and the research and training strengths of the University of Michigan combine to provide an ideal context to accomplish the specific aims of this proposal.
该申请是对以患者为导向的研究(PA-98-053)职业生涯中期研究者奖的回应,该奖项旨在支持年轻,积极和成功的临床研究者克服以患者为导向的研究的一些主要障碍:时间,资源和指导。 Sewon Kang博士代表了这样一位临床研究者,他接受了多年的专业培训,并致力于指导下一代临床研究者。 该计划的目标是进一步建立候选人独立的以患者为导向的临床研究计划,特别是在临床转化研究方面,并为他提供指导从事皮肤临床研究的学员所需的时间和资源。 该项目的活动领域是Kang博士的研究计划,重点是紫外线(UV)-A1辐射在纤维化皮肤疾病中的治疗应用,抗氧化剂在体内与人体皮肤光老化相关的UV信号传导中的作用,以及银屑病中的白细胞介素-10,沿着他指导开始临床研究者的计划。 这三个项目允许,除了在合理的研究设计,执行和分析,培训临床研究人员使用可重复的观察和可靠的文件与人类疾病相关的分子现象所需的工具的新途径的机会更传统的途径。 候选人有一个既定的记录,提供导师的前和博士后学员。 Kang博士的研究计划将为他继续培训初级临床研究人员提供背景。他的研究和指导计划将得到密歇根大学杰出的临床研究和培训计划的支持。 这些包括最近授予的机构课程,向年轻学员和初级教师(K-30)教授临床研究的基本知识,一个资金充足的综合临床研究中心,临床研究和治疗中心,临床研究设计和统计分析教育计划,以及公共卫生学院。 总之,候选人在以患者为导向的研究方面的专业知识和成就,他指导开始临床研究者的能力和承诺,以及密歇根大学的研究和培训优势结合联合收割机,为实现本提案的具体目标提供了理想的背景。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sewon Kang其他文献
Sewon Kang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sewon Kang', 18)}}的其他基金
OPEN LABEL STUDY OF TETRATHIOMOLYBDATE IN TREATMENT OF PSORIASIS VULGARIS
四硫代钼酸盐治疗寻常型银屑病的开放标签研究
- 批准号:
7199915 - 财政年份:2005
- 资助金额:
$ 12.31万 - 项目类别:
Univ of Michigan Multidisciplinary Clinical Resea**(RMI)
密歇根大学多学科临床研究**(RMI)
- 批准号:
7050494 - 财政年份:2005
- 资助金额:
$ 12.31万 - 项目类别:
University of Michigan Multidisciplinary Clinical Research (RMI)
密歇根大学多学科临床研究 (RMI)
- 批准号:
7288723 - 财政年份:2005
- 资助金额:
$ 12.31万 - 项目类别:
University of Michigan Multidisciplinary Clinical Research (RMI)
密歇根大学多学科临床研究 (RMI)
- 批准号:
7169521 - 财政年份:2005
- 资助金额:
$ 12.31万 - 项目类别:
UV-induced collagen reduction: treating skin scleroderma
紫外线诱导的胶原蛋白减少:治疗皮肤硬皮病
- 批准号:
6789958 - 财政年份:2001
- 资助金额:
$ 12.31万 - 项目类别:
UV-Induced Collagen Reduction--Treating Skin Scleroderma
紫外线诱导胶原蛋白减少——治疗皮肤硬皮病
- 批准号:
6407566 - 财政年份:2001
- 资助金额:
$ 12.31万 - 项目类别:
UV-induced collagen reduction: treating skin scleroderma
紫外线诱导的胶原蛋白减少:治疗皮肤硬皮病
- 批准号:
6512141 - 财政年份:2001
- 资助金额:
$ 12.31万 - 项目类别:
UV-induced collagen reduction: treating skin scleroderma
紫外线诱导的胶原蛋白减少:治疗皮肤硬皮病
- 批准号:
6915175 - 财政年份:2001
- 资助金额:
$ 12.31万 - 项目类别:
UV-induced collagen reduction: treating skin scleroderma
紫外线诱导的胶原蛋白减少:治疗皮肤硬皮病
- 批准号:
6605012 - 财政年份:2001
- 资助金额:
$ 12.31万 - 项目类别:
相似海外基金
Potential of Oxyresveratrol and other antioxidants to protect cells from trauma and aging
氧化白藜芦醇和其他抗氧化剂具有保护细胞免受创伤和衰老的潜力
- 批准号:
415301-2011 - 财政年份:2011
- 资助金额:
$ 12.31万 - 项目类别:
University Undergraduate Student Research Awards
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2002
- 资助金额:
$ 12.31万 - 项目类别:
Strategic Projects - Group
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2001
- 资助金额:
$ 12.31万 - 项目类别:
Strategic Projects - Group
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6359552 - 财政年份:2000
- 资助金额:
$ 12.31万 - 项目类别:
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2000
- 资助金额:
$ 12.31万 - 项目类别:
Strategic Projects - Group
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6218772 - 财政年份:1999
- 资助金额:
$ 12.31万 - 项目类别:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6098816 - 财政年份:1999
- 资助金额:
$ 12.31万 - 项目类别:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6267774 - 财政年份:1998
- 资助金额:
$ 12.31万 - 项目类别:
Mitochondrial Antioxidants, Aging and Healthspan
线粒体抗氧化剂、衰老和健康寿命
- 批准号:
8816010 - 财政年份:1997
- 资助金额:
$ 12.31万 - 项目类别:
Mitochondrial Antioxidants, Aging and Healthspan
线粒体抗氧化剂、衰老和健康寿命
- 批准号:
8431784 - 财政年份:1997
- 资助金额:
$ 12.31万 - 项目类别: